Medifast (MED) Cash Flow Statement

Click line-items for a historical chart and %

Net income	13.72M
Depreciation and amortization
Realized (gain) loss on investment securities, net	174K
Share-based compensation	1.87M
Deferred income taxes	-3.19M
Accounts receivable	502K
Inventory	-1.68M
Prepaid expenses & other current assets	-141K
Other assets	43K
Accounts payable and accrued expenses	1.77M
Income taxes	2.79M
Net cash provided by operating activities	25.67M
Sale of investment securities	26.74M
Purchase of investment securities	-26.58M
Purchase of property and equipment	-2.04M
Purchase of intangible assets
Net cash used in investing activities	-1.2M
Repayment of long-term debt	-163K
Decrease in note receivable	0
Excess tax benefits from share-based compensation	105K
Proceeds from issuance of common stock
Purchase of treasury stock	0
Net cash (used in) provided by financing activities	-9.39M
NET CHANGE IN CASH AND CASH EQUIVALENTS	15.08M
Cash and cash equivalents - beginning of the period	42.04M
Cash and cash equivalents - end of period	57.12M
Interest paid	6K
Income taxes	7.16M

Entities mentioned with MED

View All Entities